Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis

被引:22
|
作者
Prince, Puck D. [1 ]
Matser, Amy [1 ,2 ]
van Tienen, Carla [3 ]
Whittle, Hilton C. [4 ]
van der Loeff, Maarten F. Schim [1 ,5 ]
机构
[1] Amsterdam Publ Hlth Serv, Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Erasmus MC, Rotterdam, Netherlands
[4] London Sch Hyg & Trop Med, London WC1, England
[5] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immunol Amsterdam, NL-1105 AZ Amsterdam, Netherlands
关键词
HIV-2; HIV-dual; mortality; systematic review; meta-analysis; HIV-1; PLASMA VIRAL LOAD; IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; CD4 CELL PERCENTAGE; GUINEA-BISSAU; WEST-AFRICA; CROSS-REACTIVITY; FIELD-EVALUATION; INHIBITION; EPIDEMIOLOGY;
D O I
10.1097/01.SPC.0000432532.87841.78
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: As compared to HIV-1 infection, HIV-2 is less transmissible, disease progression is slower, and the mortality risk is lower. It has been suggested that HIV-2 infection inhibits the progression of HIV-1 in individuals dually infected by HIV-1 and HIV-2 (HIV-D). We examined whether the mortality rates in dually infected individuals differ from those in persons infected with either HIV-1 or HIV-2. Design: We conducted a systematic review and meta-analysis. Methods: Medline and Embase databases were searched for studies that reported the number of deaths and person-years of observation (PY) for at least two of the three HIV groups (i.e. HIV-1, HIV-2, and HIV-D). Meta-analyses were then performed with random-effects models, estimating combined mortality rate ratios (MRRs). Results: Of the 631 identified titles, six articles were included in the meta-analysis of HIV-D-infected individuals versus HIV-mono-infected persons, and seven were included in the analysis of HIV-1-mono-infected versus HIV-2-mono-infected individuals. The overall MRR of those infected with HIV-D versus HIV-1 was 1.11 [95% confidence interval (CI) 0.95-1.30]. The overall MRR of those infected with HIV-D versus HIV-2 was 1.81 (95% CI 1.43-2.30) and the MRR of those infected with HIV-1 versus HIV-2 was 1.86 (95% CI 1.44-2.39). Conclusion: HIV-2-mono-infected persons have a lower mortality rate than those mono-infected with HIV-1 and those with HIV-D. There is no evidence that HIV-2 delays progression to death in HIV-D-infected individuals.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 50 条
  • [1] Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia
    van der Loeff, MFS
    Jaffar, S
    Aveika, AA
    Sabally, S
    Corrah, T
    Harding, E
    Alabi, A
    Bayang, A
    Ariyoshi, K
    Whittle, HC
    [J]. AIDS, 2002, 16 (13) : 1775 - 1783
  • [2] Alterations of HELIOS, PLZF, and EOMES in NK cells from HIV-1, HIV-2, and dually HIV-1 and HIV-2 infected individuals
    Malone, D. F. G.
    Bachle, S. M.
    Buggert, M.
    Moll, M.
    Biague, A.
    Norrgren, H.
    Medstrand, P.
    Sandberg, J. K.
    Jansson, M.
    [J]. IMMUNOLOGY, 2014, 143 : 108 - 108
  • [3] Superinfection of an HIV-2 infected woman by HIV-1
    Huber, M.
    Boeni, J.
    Schuepbach, J.
    Guenthard, H.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S38 - S38
  • [4] Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Cote D'Ivoire
    Koblavi-Dème, S
    Kestens, L
    Hanson, D
    Otten, RA
    Borget, MY
    Bilé, C
    Wiktor, SZ
    Roels, TH
    Chorba, T
    Nkengasong, JN
    [J]. AIDS, 2004, 18 (03) : 413 - 419
  • [5] HIV-1/HIV-2 SERONEGATIVITY IN HIV-1 SUBTYPE-O INFECTED PATIENTS
    LOUSSERTAJAKA, I
    BRUNVEZINET, F
    SIMON, F
    LY, TD
    CHAIX, ML
    SARAGOSTI, S
    COUROUCE, AM
    INGRAND, D
    [J]. LANCET, 1994, 343 (8910): : 1393 - 1394
  • [6] Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients
    Honge, Bo L.
    Andersen, Morten N.
    Jespersen, Sanne
    Medina, Candida
    Correira, Faustino G.
    Jakobsen, Martin R.
    Laursen, Alex
    Erikstrup, Christian
    Moller, Holger J.
    Wejse, Christian
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (03) : 254 - 258
  • [7] CLINICAL CORRELATIONS IN HIV-1 AND HIV-2 INFECTED PATIENTS
    MONTEIROGOILLA, M
    SOUSA, AP
    GALVAO, J
    YUEH, M
    MARQUESNEVES, C
    RIBERODASILVA, J
    [J]. VISION RESEARCH, 1995, 35 : 3211 - 3211
  • [8] MORTALITY RATES IN HIV-1/2 DUAL- AND MONO-INFECTED INDIVIDUALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Prince, P.
    Matser, A.
    van Tienen, C.
    van der Loeff, M. Schim
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2013, 89 : A211 - A212
  • [9] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    [J]. AIDS, 2000, 14 : S3 - S3
  • [10] Pre-treatment mortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible for antiretroviral therapy in The Gambia, West Africa
    Togun, Toyin
    Peterson, Ingrid
    Jaffar, Shabbar
    Oko, Francis
    Okomo, Uduak
    Peterson, Kevin
    Jaye, Assan
    [J]. AIDS RESEARCH AND THERAPY, 2011, 8